Skip to main content
. 2017 Jul 26;12(7):e0180722. doi: 10.1371/journal.pone.0180722

Table 3. Summary of findings regarding the association between delayed breastfeeding association and neonatal mortality.

Outcome Population Illustrative comparative risks (95% CI) Relative effect (95% CI) Number of participants (studies) Quality of the evidence (GRADE)3
Assumed risk1
Early
Breastfeeding
Corresponding risk2
Delayed
Breastfeeding
Neonatal Mortality All infants, who ever initiated breastfeeding, surviving 2–4 days 2–23 Hours: High4
  6.9 per 1000 (2–23 Hours):  
<1 Hour: (5.9 to 8.1) 1.33 (1.13–1.56) 136,047
5.2 per 1000     (5 studies)
>24 Hours: (>24 Hours):
  11.4 per 1000 2.19 (1.73–2.77)  
  (9.0 to 14.4)  
           
All infants, who ever initiated breastfeeding, surviving 2–4 days <24 Hours: ≥24 Hours: 142,729 Moderate5
7.7 per 1000 13.1 per 1000 1.70 (1.44–2.01) (6 studies)
  (11.1 to 15.5)    
           
Exclusively breastfeeding infants, who ever initiated breastfeeding, surviving 2–4 days <24 Hours: ≥24 Hours: 65,215 Moderate5
6.9 per 1000 12.4 per 1000 1.85 (1.29–2.67) (4 studies)
  (8.9 to 18.4)    
           
Low birthweight infants, who ever initiated breastfeeding, surviving
2–4 days
<24 Hours: ≥24 Hours: 1.73 (1.38–2.18) 21,258 Moderate5

1 The assumed risk is the median risk in the 'early breastfeeding' group across all studies providing this information.

2 The corresponding risk is based on the assumed risk in the 'early breastfeeding' group and the relative effect of the intervention (and its 95% confidence interval).

3 GRADE Working Group grades of evidence description [17]: High quality: Further research is very unlikely to change our confidence in the estimate of effect.; Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.; Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.; Very low quality: We are very uncertain about the estimate.

4 All five studies are categorized as having a moderate risk of bias, but the overall strength of evidence is upgrade to 'High' because the studies are consistent, there is a large effect size (RR >2), and there is evidence dose response.

5 All studies are categorized as having a moderate risk of bias. There is no evidence of dose response (due to study design) and there is no large effect size